Bio Green Med Solution, Inc. (BGMSP) income statement

BGMSPOTCWholesale-Durable Goods, NECFiscal year ends December 31Also trades as BGMS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30

$2.41+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.96MP/E –Yield –

Bio Green Med Solution, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31	FY 2006 2006-12-31
Revenue	0	0.04	0.42	0	0	0	–	0.15	0	0.84	1.94	1.73	1.08	0.07	0.70	0.11	0.91	–	–	–
Cost of Revenue	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.36	0.42	0.55	–	–	–
Gross Profit	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.34	-0.31	0.37	–	–	–
Research & Development	0.85	6.66	19	20	15	4.76	4.66	4.33	4.24	9.48	12	18	11	6.59	9.21	6.41	9.77	–	–	–
Selling, General & Admin	–	5.39	6.72	7.38	7.46	5.88	5.02	5.37	5.25	5.52	5.73	5.89	7.78	8.58	6.54	8.83	8.54	–	–	–
General & Administrative	7.72	5.39	6.72	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Expenses	9.17	12	26	28	22	–	–	9.70	9.49	–	–	–	–	–	–	–	–	–	–	–
Total Costs & Expenses	–	–	–	28	23	11	9.68	9.70	9.49	15	18	24	19	15	16	15	19	–	–	–
Operating Income	-8.43	-12	-25	-28	-22	-11	-9.68	-9.55	-9.49	-14	-16	-22	-18	-15	-16	-15	-18	–	–	–
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.04	0.18	–	–	–
Interest & Investment Income	–	0.01	0.27	0.21	0.02	0.04	0.22	0.33	0.12	0.04	0.01	0.01	0.01	0.02	0.05	0.04	0.10	–	–	–
Other Non-Operating Income	5.44	0.01	-0.10	1.74	0.20	0.96	0.56	0.92	1.03	0.38	-0.32	-0.21	6.09	0.00	0.58	-0.41	-2.21	–	–	–
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.22	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0.04	–	–	0.01	–	–	–	0.06	0.00	0.01	-0.08	–	–	–
Pretax Income	-2.99	-12	-26	-26	-22	-9.68	-9.13	-8.63	-8.46	-14	-16	-23	-12	-15	-15	-16	-21	–	–	–
Income Tax Expense	0.01	-0.78	-3.00	-4.72	-3.73	-1.24	-1.30	-1.34	-0.99	-1.98	-2.14	-3.24	-1.67	-1.35	-0.57	-0.66	-0.95	–	–	–
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	-14	-19	-10	-14	-15	-15	–	–	–	–
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	–	0.02	0.06	0.57	-0.64	-1.13	–	–	–	–
Net Income incl. Noncontrolling Interests	–	-11	-23	–	-18	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	-3.00	-11	-23	-21	-18	-8.45	-7.83	-7.29	-7.47	-12	-14	-19	-10	-13	-15	-16	-20	-40	-24	-29
Preferred Dividends	0.06	0	0.20	0.20	0.20	0.20	0.20	0.20	0.20	–	–	–	–	–	0.36	–	–	1.23	0.31	–
Net Income to Common	-14	-11	-23	-21	-19	-12	-8.03	-7.49	-15	-12	-15	-20	-19	-14	-16	-20	-21	–	–	–
EPS (Basic)(per share)	-6.45	-502.46	-6,419.18	-28.50	-31.35	-51.30	-147.60	-186.00	-585.00	-1,050.00	-1,608.00	-3,204.00	-4,608.00	-6,048.00	-7,992.00	-13,104.00	-23,688.00	–	–	–
EPS (Diluted)(per share)	-6.45	-502.46	-6,419.18	-27.24	-31.35	-51.30	-147.60	-186.00	-585.00	-1,050.00	-1,608.00	-3,204.00	-4,608.00	-6,048.00	-7,992.00	-13,104.00	-23,688.00	–	–	–
Shares Outstanding (Basic, Weighted)(shares)	2.19	0.02	3.55	0.75	0.60	0.24	0.05	0.04	0.03	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	–	–	–
Shares Outstanding (Diluted, Weighted)(shares)	2.19	0.02	3.55	0.75	0.60	0.24	0.05	0.04	0.03	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	–	–	–
EBITDA	–	–	–	–	–	-11	-9.66	-9.52	23	-14	-16	-22	-18	-15	-16	-15	-18	–	–	–
Net Interest Income	0.06	0.01	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -128.4%

Financial strength

Current ratio: 8.63
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 547.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.83
Dividend yield: –